- CSR Summary Not Available
- NCT04019041
- Primary Citation Trial has yet to be published
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameBermekimabProduct NameTherapeutic AreaImmune System DiseasesEnrollment144% FemaleN/A% WhiteN/A
Product ClassMonoclonal AntibodySponsor Protocol Number77474462HDS2002Data PartnerJohnson & JohnsonCondition StudiedHidradenitis SuppurativaMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Statistical Analysis Plan Available
- Clinical Study Report Available